St. Louis Park, MN – According to filings with the U.S. Securities and Exchange Commission, Neochord is raising $29,247,116.00 in new funding. Sources indicate as part of senior management Chief Financial Officer, Ron Nelson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Neochord

NeoChord is a privately held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company’s flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.

To learn more about Neochord, visit http://neochord.com/

Contact:
Ron Nelson, Chief Financial Officer
952-698-7800
rnelson@neochord.com
https://www.linkedin.com/in/ronald-m-nelson-42291112/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved